M Lanz 30mg Capsule contains Lansoprazole, a proton pump inhibitor used to reduce gastric acid secretion. It is primarily indicated for the treatment of gastroesophageal reflux disease (GERD), peptic ulcer disease, Zollinger-Ellison syndrome, and eradication of Helicobacter pylori infection when used in combination with appropriate antibiotics. Lansoprazole acts by irreversibly inhibiting the H+/K+ ATPase enzyme system at the secretory surface of gastric parietal cells, thereby suppressing basal and stimulated gastric acid secretion. This reduction in acid secretion promotes healing of erosive esophagitis and ulcers and alleviates symptoms associated with acid-related disorders such as heartburn and acid regurgitation. M Lanz 30mg Capsule is typically administered orally once daily before meals; however, dosage and duration may vary based on the clinical condition and physician’s discretion. It is generally well-tolerated, with common adverse effects including headache, abdominal pain, nausea, and diarrhea. Use with caution in patients with hepatic impairment and avoid concomitant use with certain drugs metabolized by cytochrome P450 enzymes due to potential interactions. Lansoprazole should be used under medical supervision, with adherence to prescribed dosage to ensure optimal therapeutic outcomes and minimize risks.